For their full-year 2018 revenue, Xylem Inc. has forecasted that it would be in the range of US$5.1 to US$5.2 billion, up eight to 10 per cent, including growth from previously announced acquisitions. On an organic basis, Xylem’s revenue growth is anticipated to be in the range of four to six per cent.
Full-year 2018 adjusted operating margin is expected to be in the range of 14 to 14.4 per cent, resulting in adjusted earnings per share of US$2.82 to US$2.97. This represents an increase of 18 to 24 per cent from Xylem’s 2017 adjusted results. The company’s adjusted earnings outlook excludes projected integration, restructuring and realignment costs of approximately US$35 million for the year.